What Fueled The Previous Growth In The Hyperhidrosis Treatment Market?
The hyperhidrosis treatment market has seen considerable growth due to a variety of factors.
• In recent times, the hyperhidrosis treatment market has witnessed a robust growth. It is projected to expand from a worth of $1.58 billion in 2024 to $1.67 billion in 2025, with a compound annual growth rate (CAGR) of 5.9%.
Factors such as cosmetic apprehensions, awareness of the psychosocial impact, and regulatory backing have contributed to this growth during the historic period.
What Is The Expected Growth In The Hyperhidrosis Treatment Market Size Evolve over the Forecast Period?
The hyperhidrosis treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for hyperhidrosis treatment is predicted to experience significant expansion in the upcoming years, expected to reach $2.13 billion by 2029 with a compound annual growth rate (CAGR) of 6.2%.
This anticipated growth in the forecasted period can be attributed to factors such as patient-focused treatment plans, global health awareness, advancements in topical therapy methods, breakthroughs in surgical protocols, and being integrated into comprehensive dermatology practices. Anticipated trends during the forecast period encompass personalized treatment methodologies, technological progress in medical devices, research and advancements in oral treatments, the use of telemedicine for consultations and follow-ups, as well as collaborations and partnerships.
What Main Forces Are Fueling Expansion In The Hyperhidrosis Treatment Market?
The escalating incidence of diabetes mellitus is anticipated to fuel the expansion of the hyperhidrosis treatment market. Diabetes mellitus occurs when the body either doesn't produce sufficient insulin or fails to properly respond to it, resulting in abnormally high levels of blood sugar. This disease can impair the nerves that regulate sweat glands, resulting in excessive sweating or hyperhidrosis. Managing body temperature and sweat production to cool the body can be challenging with diabetes. For example, data from the Office for Health Improvement & Disparities in the UK in March 2024 indicated that the proportion of individuals with type 1 diabetes receiving all eight recommended care processes rose by 22% between March 2022 and March 2023, with a 21% increase observed in type 2 diabetes patients. Additionally, the percentage meeting the target HbA1c levels reached a record 37.9%, as reported by the National Diabetes Audit (NDA). Hence, the increasing incidence of diabetes mellitus is pushing the hyperhidrosis treatment market forward. The hyperhidrosis treatment market is prospering amidst skyrocketing healthcare expenditures. The amount expended on healthcare, covering medical costs, equipment, supplies, and medications, represents the healthcare expenditure. The escalating healthcare expenditure has heightened the awareness about hyperhidrosis and its effects on daily lives and overall quality of life of patients. This includes new treatments, surgical methods, and related health conditions. The Centers for Medicare & Medicaid Services, a department of the US Department of Health and Human Services, for example, predicted in its 2021–2030 National Health Expenditure (NHE) report in March 2022, that national health spending would rise by an average of 5.1% annually from 2021 to 2030, hitting around $6.8 trillion by 2030. Moreover, Medicare costs are predicted to grow at an annual rate of 7.2%, while Medicaid expenditures are anticipated to increase at a 5.6% annual rate during the same period. Therefore, the hyperhidrosis treatment market growth is being accelerated by the surging healthcare expenditure.
What Are The Primary Segments In The Global Hyperhidrosis Treatment Market?
The hyperhidrosis treatment market covered in this report is segmented –
1) By Treatment Type: Topical Treatments, Surgical Treatments, Botulin Toxin A, Iontophoresis, Laser Treatments, Other Treatments
2) By Route Of Administration: Oral, Injectable
3) By Disease Type: Axillary Hyperhidrosis, Palmar Hyperhidrosis, Plantar Hyperhidrosis, Other Diseases
4) By Distribution Channel: Hospitals, Ambulatory Surgical Centers, Retail Pharmacies, Online
Subsegments:
1) By Topical Treatments: Aluminum Chloride Solutions, Antiperspirants
2) By Surgical Treatments: Sympathectomy, Excision
3) By Botulin Toxin A: Injection Treatments, Combination Therapies
4) By Iontophoresis: Home Devices, Clinical Devices
5) By Laser Treatments: Microwave Therapy, Laser Ablation
6) By Other Treatments: Oral Medications, Alternative Therapies
Pre-Book The Hyperhidrosis Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Trends Are Shaping The Hyperhidrosis Treatment Market?
Leading businesses in the hyperhidrosis treatment sector are focusing on the development of wipe formulations to boost their market earnings. Wipe formulations offer a way to deliver medicinal or antiperspirant substances to the skin via a pre-soaked wipe. These are utilized to distribute antiperspirant drugs on the skin in order to regulate excessive perspiration. For example, Maruho Co. Ltd., a pharmaceutical entity based in Japan, released Rapifort Wipes 2.5% for managing primary axillary hyperhidrosis in Japan as of May 2022. The primary component, glycopyrronium tosilate hydrate, works by blocking the activation of acetylcholine receptors in sweat glands, leading to less sweat production. Daily application of this solution on each underarm using a single piece of non-woven material provided in a pack can lead to reduced sweating. It's a convenient and hygienic option, as it is designed for single use. Primary axillary hyperhidrosis is a medical condition characterized by excessive perspiration in the underarm area without any obvious reason, negatively impacting daily routines.
Who Are the Key Players In The Hyperhidrosis Treatment Market?
Major companies operating in the hyperhidrosis treatment market report are:
• Pfizer Inc.
• AbbVie Inc.
• Sanofi S.A.
• AstraZeneca PLC
• GSK PLC
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Cynosure LLC
• Ipsen SA
• Galderma S.A.
• Merz Pharma GmbH & Co. KGaA
• Daewoong Pharmaceutical Co. Ltd.
• Supernus Pharmaceuticals Inc.
• Kaken Pharmaceutical Co Ltd.
• Avanor Healthcare Ltd.
• HUGEL Inc.
• Evolus Inc.
• Revance Therapeutics Inc.
• Dermira Inc.
• Sesderma SL
• Miramar Labs Inc.
• Dermavant Sciences Inc.
• Theravida Inc.
• SweatBlock
• Brickell Biotech Inc.
• Fresh Tracks Therapeutics Inc.
• Advin Health Care Inc.
• Dermadry Laboratories Inc.
• Ulthera Inc.
• Dermata Therapeutics Inc.
What Is The Most Dominant Region In The Hyperhidrosis Treatment Market?
North America was the largest region in the hyperhidrosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hyperhidrosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
